Jan Mattsson

Track

Insider profile

Currently holds a position at Albireo Pharma Inc

Performance

Overall performance
3.1
Performance over holding periods
3.1
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Scientific Officer Albireo Pharma Inc Jan. 1, 2019 -
Chief Operating Officer Albireo Pharma Inc Nov. 3, 2016 - Jan. 1, 2019
Jan Mattsson's trades of Albireo Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-23 2023-01-23
PlS Planned sale
30,330 -44.9%
302.95
US$1,544,439 		30,330 -44.9% 302.95 US$1,544,439
2023-01-20 2023-01-19
PlS Planned sale
87,563 +42.2%
13.82
US$4,857,225 		87,563 +42.2% 13.82 US$4,857,225
2022-10-25 2022-10-24
PlS Planned sale
21,379 +49.3%
298.18
US$1,646,336 		21,379 +49.3% 298.18 US$1,646,336
2022-07-25 2022-07-22
PlS Planned sale
205 -0.4%
24.68
US$5,058 		205 -0.4% 24.68 US$5,058
2022-04-25 2022-04-22
PlS Planned sale
200 -0.3%
32.92
US$6,585 		200 -0.3% 32.92 US$6,585
2022-01-25 2022-01-24
PlS Planned sale
808 -1.4%
24.88
US$20,105 		808 -1.4% 24.88 US$20,105
2021-03-03 2021-03-03
S Sale
400 -1.1%
36.20
US$14,481 		400 -1.1% 36.20 US$14,481
2021-03-03 2021-03-02
S Sale
2,807 -6.9%
37.15
US$104,281 		2,807 -6.9% 37.15 US$104,281
2021-03-03 2021-03-02
S Sale
612 -1.5%
36.54
US$22,365 		612 -1.5% 36.54 US$22,365
2021-03-03 2021-03-02
S Sale
12,351 -23.0%
36.07
US$445,561 		12,351 -23.0% 36.07 US$445,561
2021-03-03 2021-03-01
S Sale
15,300 -22.2%
37.45
US$572,996 		15,300 -22.2% 37.45 US$572,996
2020-09-10 2020-09-08
PlS Planned sale
10,000 -29.2%
45.55
US$455,500 		10,000 -29.2% 45.55 US$455,500